Viking Thera
(VKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,779 | -22,063 | -20,578 | -14,732 | -23,404 |
| Depreciation Amortization | 1,023 | 1,263 | 2,943 | 2,081 | 1,025 |
| Accounts payable and accrued liabilities | 1,472 | -508 | 264 | 677 | 219 |
| Other Working Capital | -3,783 | 823 | 1,771 | 850 | 620 |
| Other Operating Activity | 2,315 | 1,730 | 842 | 53 | 12,808 |
| Operating Cash Flow | $-24,752 | $-18,755 | $-14,758 | $-11,071 | $-8,732 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,463 | -265,729 | -1,730 | 3,030 | -13,470 |
| Investing Cash Flow | $7,463 | $-265,729 | $-1,730 | $3,030 | $-13,470 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,111 | 305,000 | 22,999 | 11,571 | 25,415 |
| Other Financing Activity | -224 | -4,725 | -599 | -1,222 | -3,201 |
| Financing Cash Flow | $887 | $300,275 | $22,400 | $10,349 | $22,214 |
| Beginning Cash Position | 24,779 | 8,988 | 3,076 | 769 | 756 |
| End Cash Position | 8,377 | 24,779 | 8,988 | 3,076 | 769 |
| Net Cash Flow | $-16,402 | $15,791 | $5,912 | $2,307 | $13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,752 | -18,755 | -14,758 | -11,071 | -8,732 |
| Free Cash Flow | -24,752 | -18,755 | -14,758 | -11,071 | -8,732 |